Last reviewed · How we verify
Thalocid (phthalylsulfacetamide)
Thalocid (generic name: phthalylsulfacetamide) is a drug. It is currently in unknown development.
Thalocid works by inhibiting bacterial growth and replication.
Thalocid is a small molecule with the synonyms NSC-163977, Phthalylsulfacetamide, and Phthalylsulphacetamide.
At a glance
| Generic name | phthalylsulfacetamide |
|---|---|
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Imagine your body is a garden, and bacteria are weeds. Thalocid is like a weed killer that stops the weeds from growing and spreading. It does this by interfering with the bacteria's ability to make copies of themselves, ultimately helping to clear up infections.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Thalocid CI brief — competitive landscape report
- Thalocid updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Thalocid
What is Thalocid?
How does Thalocid work?
What is the generic name of Thalocid?
What development phase is Thalocid in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing